Oramed Pharmaceuticals Inc (ORMP)
2.20
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 09:40
Oramed Pharmaceuticals Cash from Financing (TTM): 51.98M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 51.98M |
September 30, 2023 | 81.15M |
June 30, 2023 | 10.92M |
March 31, 2023 | 10.92M |
December 31, 2022 | 10.78M |
September 30, 2022 | 67.17M |
June 30, 2022 | 117.88M |
March 31, 2022 | 139.73M |
November 30, 2021 | 162.87M |
August 31, 2021 | 102.89M |
May 31, 2021 | 49.35M |
February 28, 2021 | 47.47M |
November 30, 2020 | 24.36M |
August 31, 2020 | 23.79M |
May 31, 2020 | 22.31M |
February 29, 2020 | 2.329M |
November 30, 2019 | 0.013M |
August 31, 2019 | 0.00 |
May 31, 2019 | 16.49M |
February 28, 2019 | 16.78M |
November 30, 2018 | 17.49M |
August 31, 2018 | 22.65M |
May 31, 2018 | 7.427M |
February 28, 2018 | 7.144M |
November 30, 2017 | 6.426M |
Date | Value |
---|---|
August 31, 2017 | 1.586M |
May 31, 2017 | 0.431M |
February 28, 2017 | 0.483M |
November 30, 2016 | 12.20M |
August 31, 2016 | 12.04M |
May 31, 2016 | 16.81M |
February 29, 2016 | 16.76M |
November 30, 2015 | 5.052M |
August 31, 2015 | 9.721M |
May 31, 2015 | 4.843M |
February 28, 2015 | 4.986M |
November 30, 2014 | 21.47M |
August 31, 2014 | 16.64M |
May 31, 2014 | 21.01M |
February 28, 2014 | 20.87M |
November 30, 2013 | 4.366M |
August 31, 2013 | 5.824M |
May 31, 2013 | 4.940M |
February 28, 2013 | 4.940M |
November 30, 2012 | 4.947M |
August 31, 2012 | 3.489M |
May 31, 2012 | 0.00 |
February 29, 2012 | 0.5882M |
November 30, 2011 | 3.394M |
August 31, 2011 | 3.694M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
Aug 2019
162.87M
Maximum
Nov 2021
49.60M
Average
24.36M
Median
Nov 2020
Cash from Financing (TTM) Benchmarks
Inogen Inc | 0.96M |
Petros Pharmaceuticals Inc | 11.54M |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |